Cubist Pharmaceuticals (CBST): Q2 EPS of $0.68 beats by $0.17. Revenue of $230.6M (+30.4% Y/Y)...

|By:, SA News Editor
Cubist Pharmaceuticals (CBST): Q2 EPS of $0.68 beats by $0.17. Revenue of $230.6M (+30.4% Y/Y) beats by $4M. Shares +4.8% AH. (PR)